Up-regulation of heme oxygenase-1 after infarct initiation reduces mortality, infarct size and left ventricular remodeling: experimental evidence and proof of concept.
BACKGROUND
Up-regulation of HO-1 by genetic manipulation or pharmacological pre-treatment has been reported to provide benefits in several animal models of myocardial infarction (MI). However, its efficacy following MI initiation (as in clinical reality) remains to be tested. Therefore, this study investigated whether HO-1 over-expression, by cobalt protoporphyrin (CoPP) administered after LAD ligation, is still able to improve functional and structural changes in left ventricle (LV) in a rat model of 4-week MI.


METHODS
A total of 144 adult male Wistar rats were subjected to either left anterior coronary artery ligation or sham-operation. The effect of CoPP treatment (5 mg/kg i.p. at the end of the surgical session and, then, once a week for 4 weeks) was evaluated on the basis of survival, electro- and echocardiography, plasma levels of B-type natriuretic peptide (BNP), endothelin-1 and prostaglandin E2, coronary microvascular reactivity, MI size, LV wall thickness and vascularity. Besides, the expression of HO-1 and connexin-43 in different LV territories was assessed by western blot analysis and immunohistochemistry, respectively.


RESULTS
CoPP induced an increased expression of HO-1 protein with >16 h delay. CoPP treatment significantly reduced mortality, MI size, BNP concentration, ECG alterations, LV dysfunction, microvascular constriction, capillary rarefaction and restored connexin-43 expression as compared to untreated MI. These functional and structural changes were paralleled by increased HO-1 expression in all LV territories. HO activity inhibition by tin-mesoporphyrin abolished the differences between CoPP-treated and untreated MI animals.


CONCLUSIONS
This is the first report demonstrating the putative role of pharmacological induction of HO-1 following coronary occlusion to benefit infarcted and remote territories, leading to better cardiac function in a 4-week MI outcome.
CNR Institute of Clinical Physiology, Via G Moruzzi 1, 56124 Pisa, Italy. kusmic@ifc.cnr.it.
Claudia
C
Kusmic
Cristina
C
Barsanti
Marco
M
Matteucci
Nicoletta
N
Vesentini
Gualtiero
G
Pelosi
Nader G
NG
Abraham
Antonio
A
L'Abbate
D000818:Animals; D051547:Heme Oxygenase-1 / Q000378:metabolism*; D008297:Male; D009203:Myocardial Infarction / Q000201:enzymology / Q000378:metabolism* / Q000401:mortality; D051381:Rats; D017208:Rats, Wistar; D015854:Up-Regulation; D020257:Ventricular Remodeling
D051547:Heme Oxygenase-1